Moreover, a series of joint analyses between tau PET and resting‐state functional magnetic resonance imaging (fMRI) contribute significantly to our understanding of the association between pathologic tau aggregation and functional connectivity in AD and other tauopathies (Cope et al., 2018; Franzmeier et al., 2019, 2022; Franzmeier, Neitzel, et al., 2020; Schoonhoven et al., 2023; Schumacher et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.